Skip to main content
Premium Trial:

Request an Annual Quote

Hybrigenics COO Trades in Frequent Flier Life for Proteomics in Paris

Premium

The new COO at Hybrigenics has made a number of jumps in her career. Starting out in research, she headed to development and later moved again when an offer came along and piqued her curiosity about working on the business side. Now, she’s making the shift from big pharma to a small proteomics company. “It is indeed a major new challenge in my career,” says Anne-Fabienne Weitsch.

Formerly senior director of licensing and business development at Johnson & Johnson, Weitsch got first-hand experience navigating the biotech world (and airports: “I was living in Belgium and spending 40 percent of my time in the US,” she says). After eight years at J&J and previous time in R&D at her native Switzerland’s CIBA, she decided she was ready to move to the smaller realm of proteomics and functional proteomics at Paris-based Hybrigenics.

Since she’s already well-versed in the field, “the real learning curve will be the business operations of the biotech company,” she says. “My role will be very operational, more turned toward internal [issues].” That means less traveling, but hey, it’s Paris.

— Meredith Salisbury

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.